Patent for Favipiravir rejected in Thailand

14 Sept 06:34 Key points summarised by AI

Thailand's Intellectual Property Department rejected the patent application for the Japanese anti-viral drug Favipiravir, citing a failure to meet legal manufacturing quality requirements.
This rejection removes monopolistic rights, paving the way for the Government Pharmaceutical Organization and other Thai firms to domestically produce Favipiravir for local consumption, though the applicant has 60 days to appeal the decision.

Speculation growing over merger between Bhumjaithai and Kla Tham parties

Today 16:46 Key points summarised by AI

A dinner between Bhumjaithai and Kla Tham party leaders sparked rumors of a potential merger, though Bhumjaithai's leader, Anutin, downplayed it as a casual meal.
The meeting is widely interpreted as a strategic message from Bhumjaithai to the Pheu Thai party, signaling alternative support ahead of an upcoming no-confidence debate.
Thailand's Constitution (Section 99) currently prohibits direct mergers of parties with sitting MPs during the House's term, a rule designed to prevent the 'buying and selling' of MPs.
While direct mergers are restricted, MPs can still switch parties if dismissed by a three-fourths party vote or if their party dissolves, allowing for indirect political realignments.
Kla Tham's voting behavior in the censure debate will demonstrate its loyalty to the government, potentially influencing future political dynamics despite current merger restrictions.